RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.28

EPS Forecast

$149.8

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon

Market expectations

EPS Expectation:

-$1.28

Revenue Expectation:

$149.8

EPS Surprise Expectation:

$0.047

Revenue Surprise Expectation:

$3

Post-release price volatility - High

Post-release Overnight Move:

±7.0%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: